PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRIâ¯+â¯Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer.
Dig Liver Dis
; 53(4): 420-426, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33358124
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Esophageal Neoplasms
/
Adenocarcinoma
/
Antineoplastic Combined Chemotherapy Protocols
Type of study:
Clinical_trials
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
En
Journal:
Dig Liver Dis
Journal subject:
GASTROENTEROLOGIA
Year:
2021
Document type:
Article
Affiliation country:
France
Country of publication:
Netherlands